Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

Detalles Bibliográficos
Autores principales: Hartley, James Leon, Bailey, Neil, Sharma, Asheesh, Shawki, Howida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900021/
https://www.ncbi.nlm.nih.gov/pubmed/35246429
http://dx.doi.org/10.1136/bcr-2021-244638
_version_ 1784664017857413120
author Hartley, James Leon
Bailey, Neil
Sharma, Asheesh
Shawki, Howida
author_facet Hartley, James Leon
Bailey, Neil
Sharma, Asheesh
Shawki, Howida
author_sort Hartley, James Leon
collection PubMed
description We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.
format Online
Article
Text
id pubmed-8900021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89000212022-03-22 Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases Hartley, James Leon Bailey, Neil Sharma, Asheesh Shawki, Howida BMJ Case Rep Case Report We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome. BMJ Publishing Group 2022-03-04 /pmc/articles/PMC8900021/ /pubmed/35246429 http://dx.doi.org/10.1136/bcr-2021-244638 Text en © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
spellingShingle Case Report
Hartley, James Leon
Bailey, Neil
Sharma, Asheesh
Shawki, Howida
Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title_full Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title_fullStr Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title_full_unstemmed Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title_short Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases
title_sort nephrotic syndrome with minimal change disease after the pfizer-biontech covid-19 vaccine: two cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900021/
https://www.ncbi.nlm.nih.gov/pubmed/35246429
http://dx.doi.org/10.1136/bcr-2021-244638
work_keys_str_mv AT hartleyjamesleon nephroticsyndromewithminimalchangediseaseafterthepfizerbiontechcovid19vaccinetwocases
AT baileyneil nephroticsyndromewithminimalchangediseaseafterthepfizerbiontechcovid19vaccinetwocases
AT sharmaasheesh nephroticsyndromewithminimalchangediseaseafterthepfizerbiontechcovid19vaccinetwocases
AT shawkihowida nephroticsyndromewithminimalchangediseaseafterthepfizerbiontechcovid19vaccinetwocases

Ejemplares similares